NCT07035392 2025-06-25Adebrelimab + Chemotherapy as Neoadjuvant Therapy for Resectable NSCLCZhangzhou Municipal HospitalPhase 2 Not yet recruiting32 enrolled
NCT06506292 2024-07-17A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastroesophageal Junction Cancer (GC/GEJC)Tianjin Medical University Cancer Institute and HospitalPhase 2 Recruiting25 enrolled